Drawing for COSOMIL

USPTO serial 79366760

COSOMIL

Reviewed by CopyMark Law Group

Reg. 7416459Status 700Registered
Filing date
Status date
Registration date
Jun 18, 2024
Examiner
FLETCHER, TRACY L
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with COSOMIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ee Ming T. Bahk

Ee Ming T. Bahk Oliff PLCP.O. Box 320850Alexandria, VA 22320-4850United States

Goods and services

ClassDescriptionStatusFirst use
042Computer programming for the medical sector; design of medical diagnostic apparatus and product development in the field of medical diagnostic apparatus; testing, inspection and research services in the fields of pharmaceuticals and foodstuffs; medical research; scientific research for medical purposes; biomedical research; providing information about medical and scientific research in the field of pharmaceuticals; pharmaceutical product evaluation; medical and scientific research, namely, conducting clinical trials for others; research and development services relating to medicines being research and development of medicines; consultancy relating to pharmaceutical research and development; research and development of medical technology being research and development in the pharmaceutical and biotechnology fields; scientific research and development; medical research and development in the field of pharmaceuticalsACTIVE—
044Provision of medical information; medical examination services; medical screening; conducting medical physical evaluation services; disease diagnosis services being performing diagnosis of diseases; medical analysis for the diagnosis and treatment of persons; medical counselling; medical testing for diagnostic or treatment purposes; health related consultancy and information services relating to medical products; medical equipment rental; health risk assessment services; health careACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 5, 2024FINAFINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Sep 18, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 18, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jun 18, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 16, 2024GPNXNOTIFICATION PROCESSED BY IB—
Apr 2, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 2, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 27, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 27, 2024OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 13, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 29, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 29, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 28, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 28, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 4, 2023RFNPREFUSAL PROCESSED BY IB—
Nov 15, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 15, 2023RFRRREFUSAL PROCESSED BY MPU—
Nov 15, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 14, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 13, 2023DOCKASSIGNED TO EXAMINER—
Apr 21, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 17, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 14, 2023LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Apr 6, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance